doi: 10.1016/0896-6273(91)90273-3.
BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
Affiliations
- PMID: 1742020
- DOI: 10.1016/0896-6273(91)90273-3
Item in Clipboard
BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
Neuron.
1991 Nov.
Abstract
In recent years, nerve growth factor (NGF) has gained attention as a potential therapeutic agent for Alzheimer's disease (AD). To study the expression of NGF and its homologs, brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3), postmortem samples of hippocampus from AD and control donors were examined by in situ hybridization. Hybridization signal for BDNF, but not NGF or NT-3, was decreased in samples of hippocampus from donors with AD. Decreased transcript abundance of BDNF mRNA in hippocampi of individuals with AD was verified by an RNAase protection assay. These results suggest the possibility that decreased expression of BDNF may contribute to the progression of cell death in AD.
Similar articles
-
Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas.Arch Neurol. 2000 Jun;57(6):846-51. doi: 10.1001/archneur.57.6.846. Arch Neurol. 2000. PMID: 10867782
-
Brain-derived neurotrophic factor and neurotrophin-4 increase neurotrophin-3 expression in the rat hippocampus.Int J Dev Neurosci. 1994 Dec;12(8):745-51. doi: 10.1016/0736-5748(94)90054-x. Int J Dev Neurosci. 1994. PMID: 7747601
-
Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment.Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10352-6. doi: 10.1073/pnas.88.22.10352. Proc Natl Acad Sci U S A. 1991. PMID: 1946455 Free PMC article.
-
The synthesis of nerve growth factor and brain-derived neurotrophic factor in hippocampal and cortical neurons is regulated by specific transmitter systems.Ann N Y Acad Sci. 1991;640:86-90. doi: 10.1111/j.1749-6632.1991.tb00196.x. Ann N Y Acad Sci. 1991. PMID: 1776765 Review.
-
Growth Factor Gene Therapy for Alzheimer's Disease.J Alzheimers Dis. 2024;101(s1):S433-S441. doi: 10.3233/JAD-240545. J Alzheimers Dis. 2024. PMID: 39422960 Review.
Cited by
-
Serum BDNF as a Potential Biomarker of Alzheimer's Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy.Front Neurol. 2021 Apr 23;12:653267. doi: 10.3389/fneur.2021.653267. eCollection 2021. Front Neurol. 2021. PMID: 33967943 Free PMC article.
-
Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease.PLoS One. 2021 Mar 4;16(3):e0240342. doi: 10.1371/journal.pone.0240342. eCollection 2021. PLoS One. 2021. PMID: 33661922 Free PMC article.
-
Activation of TrkB-Akt signaling rescues deficits in a mouse model of SCA6.Sci Adv. 2022 Sep 16;8(37):eabh3260. doi: 10.1126/sciadv.abh3260. Epub 2022 Sep 16. Sci Adv. 2022. PMID: 36112675 Free PMC article.
-
NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection?Mol Cell Biochem. 2013 Apr;376(1-2):189-95. doi: 10.1007/s11010-013-1567-0. Epub 2013 Jan 29. Mol Cell Biochem. 2013. PMID: 23358924
-
Brain-Derived Neurotrophic Factor Signaling in the Pathophysiology of Alzheimer's Disease: Beneficial Effects of Flavonoids for Neuroprotection.Int J Mol Sci. 2021 May 27;22(11):5719. doi: 10.3390/ijms22115719. Int J Mol Sci. 2021. PMID: 34071978 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
